Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway
Abstract Background Sepsis is a severe medical condition that ranks among the top 10 causes of death worldwide and which has permanently high incidence rates. Mesenchymal stem cells (MSCs) have been found to be potent modulators of immune responses. More importantly, there is evidence that MSCs have...
Main Authors: | Leonardo Pedrazza, Monica Cubillos-Rojas, Fernanda Cristina de Mesquita, Carolina Luft, Aline Andrea Cunha, Jose Luis Rosa, Jarbas Rodrigues de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-017-0734-8 |
Similar Items
-
Immunomodulatory Effects of Colistin on Macrophages in Rats by Activating the p38/MAPK Pathway
by: Jin Wang, et al.
Published: (2019-06-01) -
MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease
by: Weiheng Zhao, et al.
Published: (2018-03-01) -
Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis
by: Johnatas D. Silva, et al.
Published: (2019-08-01) -
Role of phosphatases in controlling arabidopsis mapk signalling cascades
by: Lee, Jin Suk
Published: (2008) -
Role of phosphatases in controlling arabidopsis mapk signalling cascades
by: Lee, Jin Suk
Published: (2008)